Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency.

Kim, J J; Thrasher, A J; Jones, A M; Davies, E G; Cale, C M

Kim, J J; Thrasher, A J; Jones, A M; Davies, E G; Cale, C M.

Affiliation

Kim JJ; Department of Immunology, Great Ormond Street Hospital, London, UK.

Br J Haematol ; 138(1): 94-6, 2007 Jul.

Article in En | MEDLINE | ID: mdl-17498197

Subject(s)

Anemia, Hemolytic, Autoimmune/drug therapy; Antibodies, Monoclonal/therapeutic use; Immunologic Deficiency Syndromes/drug therapy; Immunologic Factors/therapeutic use; Adolescent; Anemia, Hemolytic, Autoimmune/immunology; Antibodies, Monoclonal, Murine-Derived; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Immunologic Deficiency Syndromes/complications; Infant; Male; Neutropenia/drug therapy; Neutropenia/immunology; Rituximab; Thrombocytopenia/drug therapy; Thrombocytopenia/immunology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Immunologic Deficiency Syndromes / Immunologic Factors / Anemia, Hemolytic, Autoimmune / Antibodies, Monoclonal Limits: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Br J Haematol Year: 2007 Document type: Article

Search on Google

XML

PubMed Links